Cardiovascular medicine
Research activity includes myocardial infarction and post-infarction care, with interest in preventing recurrent ischemic events, heart failure, ventricular arrhythmia, and cardiac arrest. The clinical focus also extends to revascularization and longer-term outcomes after acute coronary disease.
- Myocardial infarction
- Heart failure
- Ischemic stroke
- Ventricular arrhythmia
Work in this area reflects attention to secondary prevention and cardiovascular risk reduction in patients recovering from major coronary events.
Respiratory disease
Clinical research covers chronic obstructive pulmonary disease, with emphasis on severe airflow limitation, exacerbation prevention, and treatment selection guided by inflammatory markers such as eosinophils. The portfolio also includes interest in long-term symptom control and reduction of respiratory admissions.
- Chronic obstructive pulmonary disease (COPD)
- Exacerbation prevention
- Inhaled corticosteroids
- Azithromycin
This area is centered on optimizing care for patients with advanced COPD and frequent respiratory deterioration.
Dermatology and inflammatory skin disease
Research includes hidradenitis suppurativa, a chronic inflammatory skin disorder marked by pain, nodules, and recurrent lesions. The therapeutic interest is in reducing disease activity and improving clinical severity measures over time.
- Hidradenitis suppurativa
- Inflammatory skin disease
- Lesion burden
- Disease activity
The dermatology portfolio reflects a focus on persistent inflammatory conditions that require ongoing symptom management.
Psychiatry
Clinical work in mental health centers on bipolar disorder type II, with interest in mood stabilization, relapse prevention, and differentiation of antimanic and antidepressant effects. The research landscape is directed toward treatment choices relevant to long-term psychiatric symptom control.
- Bipolar disorder, type II
- Mood stabilization
- Relapse prevention
- Lithium and lamotrigine
This area reflects sustained interest in managing recurrent affective symptoms and improving outcomes in BDII.
Oncology
Research activity includes esophageal squamous cell carcinoma, with attention to HER2-positive disease and the integration of chemotherapy, immunotherapy, and targeted treatment approaches. The therapeutic focus is on advanced gastrointestinal cancer care.
- Esophageal cancer
- HER2-positive esophageal squamous cell carcinoma
- Immunotherapy
- Targeted therapy
The oncology portfolio highlights interest in treatment strategies for aggressive upper gastrointestinal malignancies.
